[1]VIVEROS-CARRE OD,FERNANDES A,PAREJA R.Updates on cervical cancer prevention[J].Int J Gynecol Cancer,2023,33(3):394-402.
[2]GAN Q,HUANG X,ZHAO W,et al.AC010883.5 promotes cell proliferation,invasion,migration,and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway[J].BMC Cancer,2023,23(1):364-374.
[3]YANG D,YANG R,SHEN J,et al.Sinensetin attenuates oxygen-glucose deprivation/reperfusion-induced neurotoxicity by MAPK pathway in human cerebral microvascular endothelial cells[J].J Appl Toxicol,2022,42(4):683-693.
[4]LI X,LI Y,WANG Y,et al.Sinensetin suppresses angiogenesis in liver cancer by targeting the VEGF/VEGFR2/AKT signaling pathway[J].Exp Ther Med,2022,23(5):360-370.
[5]PICCOLO S,PANCIERA T,CONTESSOTTO P,et al.YAP/TAZ as master regulators in cancer:modulation,function and therapeutic approaches[J].Nat Cancer,2023,4(1):9-26.
[6]ABUDOUKERIMU A,HASIMU A.HIF-1α regulates the progression of cervical cancer by targeting YAP/TAZ[J].J Oncol,2022,2022:3814809.
[7]LI L,JIANG H,LI Y,et al.Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of Hippo pathway[J].Aging (Albany NY),2023,15(12):5426-5444.
[8]WU Q,MIAO X,ZHANG J,et al.Astrocytic YAP protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model through TGF-β signaling[J].Theranostics,2021,11(17):8480-8499.
[9]PONTE LGS,PAVAN ICB,MANCINI MCS,et al.The hallmarks of flavonoids in cancer[J].Molecules,2021,26(7):2029-2083.
[10]HUANG B,ZHAI M,QIN A,et al.Sinensetin flavone exhibits potent anticancer activity against drug-resistant human gallbladder adenocarcinoma cells by targeting PTEN/PI3K/AKT signalling pathway,induces cellular apoptosis and inhibits cell migration and invasion[J].J BUON,2020,25(2):1251-1256.
[11]KIM SM,HA SE,LEE HJ,et al.Sinensetin induces autophagic cell death through p53-related AMPK/mTOR signaling in hepatocellular carcinoma HepG2 cells[J].Nutrients,2020,12(8):2462-2478.
[12]CHEN L,QING J,XIAO Y,et al.TIM-1 promotes proliferation and metastasis,and inhibits apoptosis,in cervical cancer through the PI3K/AKT/p53 pathway[J].BMC Cancer,2022,22(1):370-386.
[13]CASTILLO FERRER C,BERTHENET K,ICHIM G.Apoptosis-fueling the oncogenic fire[J].FEBS J,2021,288(15):4445-4463.
[14]LI Z,ZHOU Q,LIU X,et al.Lycorine upregulates the expression of RMB10,promotes apoptosis and inhibits the proliferation and migration of cervical cancer cells[J].Int J Mol Med,2022,50(6):145-154.
[15]PENG T,LIN S,MENG Y,et al.LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing LOXL2-induced epithelial-mesenchymal transition (EMT)[J].Cell Cycle,2022,21(17):1827-1841.
[16]XIN W,ZHANG J,ZHANG H,et al.CLCA2 overexpression suppresses epithelial-to-mesenchymal transition in cervical cancer cells through inactivation of ERK/JNK/p38-MAPK signaling pathways[J].BMC Mol Cell Biol,2022,23(1):44-53.
[17]徐声铭,吴靖,张志愿.YAP/TAZ在肿瘤微环境中作用的研究进展[J].现代肿瘤医学,2019,27(19):3539-3542.
XU SM,WU J,ZHANG ZY.The research progress of YAP/TAZ in tumor microenvironment[J].Modern Oncology,2019,27(19):3539-3542.
[18]WANG L,LI J,WANG R,et al.NGF signaling interacts with the Hippo/YAP pathway to regulate cervical cancer progression[J].Front Oncol,2021,11(1):1-12.
[19]HUANG J,YANG J,ZHANG Y,et al.FTO promotes cervical cancer cell proliferation,colony formation,migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway[J].Exp Cell Res,2023,427(1):1-13.
[20]KIM SH,BASILI T,DOPESO H,et al.Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix[J].J Pathol,2022,257(5):635-649.
[21]XIU Z,LIU J,WU X,et al.Cytochalasin H isolated from mangrove-derived endophytic fungus inhibits epithelial-mesenchymal transition and cancer stemness via YAP/TAZ signaling pathway in non-small cell lung cancer cells[J].J Cancer,2021,12(4):1169-1178.
[22]LIU Z,HAYASHI H,MATSUMURA K,et al.Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer[J].Br J Cancer,2023,128(5):844-856.